Study to Evaluate the Pharmacokinetics of Tezepelumab in Children With Asthma
Clinical trial NCT04673630 · COMPLETED
Trial details
- NCT number
- NCT04673630
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-23
- Primary completion
- 2022-09-27
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.